IDENTIFICATION OF THERAPEUTICALLY TARGETABLE MOLECULES AND PATHWAYS FOR THE TREATMENT OF CYSTIC KIDNEYS IN TUBEROUS SCLEROSIS COMPLEX
$761,506FY2025Defense Health AgencyDOD
University Of New Mexico, Albuquerque NM
University Of New Mexico, Albuquerque NM